These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Treatment of ventriculitis caused by Staphylococcus epidermidis on equipment with the combination of fosfomycin and an aminoglycoside. Course of ventricular levels of fosfomycin]. Boulard G; Quentin C; Scontrini G; Dautheribes M; Pouguet P; Sabathie M Pathol Biol (Paris); 1983 Jun; 31(6):525-7. PubMed ID: 6348662 [TBL] [Abstract][Full Text] [Related]
23. [Cefotaxime CSF levels in children with purulent meningitis (author's transl)]. Borderon JC; Prieur D; Huguet B Nouv Presse Med; 1981 Feb; 10(8):580-4. PubMed ID: 6259596 [TBL] [Abstract][Full Text] [Related]
25. Emergence of resistance to multiple beta-lactams in Enterobacter cloacae during treatment for neonatal meningitis with cefotaxime. Heusser MF; Patterson JE; Kuritza AP; Edberg SC; Baltimore RS Pediatr Infect Dis J; 1990 Jul; 9(7):509-12. PubMed ID: 2371083 [No Abstract] [Full Text] [Related]
26. Ampicillin-aminoglycoside combinations as initial treatment for neonatal septicaemia or meningitis. A retrospective evaluation of 12 years' experience. Tessin I; Trollfors B; Thiringer K; Larsson P Acta Paediatr Scand; 1991 Oct; 80(10):911-6. PubMed ID: 1755296 [TBL] [Abstract][Full Text] [Related]
27. Cefotaxime and aminoglycoside treatment of meningitis caused by gram-negative enteric organisms. Kaplan SL; Patrick CC Pediatr Infect Dis J; 1990 Nov; 9(11):810-4. PubMed ID: 2263430 [TBL] [Abstract][Full Text] [Related]
28. [Comparison of the efficacy of cefotaxime alone and the combination cefazolin-tobramycin in the treatment of enterobacterial septicemia]. Arich C; Gouby A; Bengler C; Ardilouze JL; Dubois A; Joubert P; Hansel S; Janbon C; Fabre S Pathol Biol (Paris); 1987 May; 35(5):613-5. PubMed ID: 3302868 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial. del Río A; Gasch O; Moreno A; Peña C; Cuquet J; Soy D; Mestres CA; Suárez C; Pare JC; Tubau F; Garcia de la Mària C; Marco F; Carratalà J; Gatell JM; Gudiol F; Miró JM; Clin Infect Dis; 2014 Oct; 59(8):1105-12. PubMed ID: 25048851 [TBL] [Abstract][Full Text] [Related]
30. MRSA meningitis in postoperative patients. Report of 4 cases. Sakamoto T; Kikuchi K; Mineura K; Kowada M; Nakagomi O Jpn J Antibiot; 1990 Jun; 43(6):1137-42. PubMed ID: 2232144 [TBL] [Abstract][Full Text] [Related]
31. Treatment failures of cefotaxime and latamoxef in meningitis caused by Enterobacter and Serratia spp. Eng RH; Cherubin CE; Pechere JC; Beam TR J Antimicrob Chemother; 1987 Dec; 20(6):903-11. PubMed ID: 3501999 [TBL] [Abstract][Full Text] [Related]
32. Treatment of childhood bacterial meningitis. Lecour H; Seara A; Cordeiro J; Miranda M Infection; 1989; 17(5):343-6. PubMed ID: 2689353 [TBL] [Abstract][Full Text] [Related]
33. [Cefotaxime in the treatment of purulent meningitis in children (author's transl)]. Borderon JC; Despert F; Santini JJ; Laugier J; Grenier B; Boulard P Nouv Presse Med; 1981 Feb; 10(8):634-8. PubMed ID: 6259609 [TBL] [Abstract][Full Text] [Related]
34. [Comparison of fosfomycin-penicillin M and penicillin M-gentamycin. Apropos of 35 severe infections caused by methicillin-sensitive Staphylococcus aureus]. Baron D; Touze MD; Tasseau F; Reynaud A; Derriennic M; Courtieu AL Rev Med Interne; 1987; 8(1):109-14. PubMed ID: 3645705 [TBL] [Abstract][Full Text] [Related]
35. [Staphylococcus aureus resistant to cloxacillin: treatment with fosfomycin-rifampicin]. Wolff M; Nercelles P; Pepay K Rev Med Chil; 1984 Jul; 112(7):665-71. PubMed ID: 6569621 [No Abstract] [Full Text] [Related]
36. Bacteriological evaluation of fosfomycin in clinical studies. Rodríguez A; Gallego A; Olay T; Mata JM Chemotherapy; 1977; 23 Suppl 1():247-58. PubMed ID: 832523 [TBL] [Abstract][Full Text] [Related]
37. [In vitro evaluation of the activity and interactions of cefotaxime and its metabolite desacetylcefotaxime against strains of enterobacteria, staphylococci and Bacteroides fragilis isolated from hospital infections]. Pitzus E G Ital Chemioter; 1989; 36(1-3):57-64. PubMed ID: 2488914 [TBL] [Abstract][Full Text] [Related]
38. [Antibiotic sensitivity of the main opportunistic pathogenic aerobic bacteria]. Minukhin VV; Tsyganenko AIa; Kravtsova VI; Arkushenko LL; Stepanenko TV Antibiot Khimioter; 1990 Mar; 35(3):36-8. PubMed ID: 2113800 [TBL] [Abstract][Full Text] [Related]
39. [Treatment of neurosurgical bacterial meningitis using the combination of ceftriaxone-fosfomycin]. Stahl JP; Croize J; Baud A; Bru JP; de Rougemont P; Le Noc P; Micoud M Pathol Biol (Paris); 1986 May; 34(5):479-82. PubMed ID: 3534726 [TBL] [Abstract][Full Text] [Related]